Drug profile · INN
sulfisoxazole diolamine
SULFISOXAZOLE DIOLAMINE
sulfisoxazole diolamine (SULFISOXAZOLE DIOLAMINE) is a bacterial dihydropteroate synthase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — sulfisoxazole diolamine
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
sulfisoxazole diolamine (SULFISOXAZOLE DIOLAMINE) is a bacterial dihydropteroate synthase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial dihydropteroate synthase inhibitor
Primary target: Dihydropteroate synthase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is sulfisoxazole diolamine?
sulfisoxazole diolamine (SULFISOXAZOLE DIOLAMINE) is a bacterial dihydropteroate synthase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for sulfisoxazole diolamine?
SULFISOXAZOLE DIOLAMINE is a marketed brand name for sulfisoxazole diolamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sulfisoxazole diolamine?
sulfisoxazole diolamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.